(Q53190286)

12 May 2018

title

Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. (English)

1 reference

12 May 2018

1 reference

4

Karen Lu

1 reference

12 May 2018

David Gershenson

5

object named as

David M Gershenson

1 reference

12 May 2018

author name string

Ann H Klopp

1

1 reference

12 May 2018

Anuja Jhingran

2

1 reference

12 May 2018

Lois Ramondetta

3

1 reference

12 May 2018

Patricia J Eifel

6

1 reference

12 May 2018

language of work or name

English

0 references

publication date

25 July 2009

1 reference

12 May 2018

published in

Gynecologic Oncology

1 reference

12 May 2018

volume

115

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

6-11

1 reference

12 May 2018

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Adjuvant Brachytherapy Removes Survival Disadvantage of Local Disease Extension in Stage IIIC Endometrial Cancer: A SEER Registry Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.06.035

10.1016/J.YGYNO.2009.06.035

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

release_4aid6mboxvhjxkskdqqm646d64

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4aid6mboxvhjxkskdqqm646d64

mapped directly with Wikidata item

24 November 2022

based on heuristic

OpenCitations bibliographic resource ID

0 references

1 reference

12 May 2018